WYNNEFIELD CAPITAL INC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WYNNEFIELD CAPITAL INC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2024$14,040
+208.2%
13,0000.0%0.01%
+200.0%
Q4 2023$4,556
-25.3%
13,0000.0%0.00%
-33.3%
Q3 2023$6,097
-57.4%
13,0000.0%0.00%
-57.1%
Q2 2023$14,300
-7.6%
13,0000.0%0.01%
-30.0%
Q1 2023$15,470
-20.1%
13,0000.0%0.01%
-9.1%
Q4 2022$19,370
-7.8%
13,0000.0%0.01%0.0%
Q3 2022$21,000
+110.0%
13,0000.0%0.01%
+120.0%
Q2 2022$10,000
-56.5%
13,0000.0%0.01%
-44.4%
Q1 2022$23,000
+4.5%
13,0000.0%0.01%
+12.5%
Q4 2021$22,000
-18.5%
13,0000.0%0.01%
-46.7%
Q3 2021$27,000
-6.9%
13,0000.0%0.02%
+15.4%
Q2 2021$29,000
-19.4%
13,0000.0%0.01%
-27.8%
Q1 2021$36,000
-2.7%
13,0000.0%0.02%
-5.3%
Q4 2020$37,000
+37.0%
13,0000.0%0.02%
+11.8%
Q3 2020$27,000
-54.2%
13,0000.0%0.02%
-60.5%
Q2 2020$59,000
-44.3%
13,0000.0%0.04%
-57.4%
Q1 2020$106,00013,0000.10%
Other shareholders
RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 3,510,000$6,318,0005.40%
Cowen Prime Advisors LLC 4,162,500$7,493,0003.15%
Athyrium Capital Management, LP 2,202,420$3,964,0001.41%
AWM Investment Company, Inc. 5,081,901$9,147,0001.18%
Parkman Healthcare Partners LLC 671,817$1,209,0000.35%
ESSEX INVESTMENT MANAGEMENT CO LLC 799,841$1,440,0000.18%
Rubric Capital Management LP 1,076,587$1,938,0000.07%
TITLEIST CAPITAL, LLC 180,093$324,0000.06%
Clear Harbor Asset Management, LLC 266,972$481,0000.06%
Frontier Wealth Management LLC 64,605$2,701,0000.03%
View complete list of RECRO PHARMA INC shareholders